| 000 | 01697 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516053557.0 | ||
| 264 | 0 | _c20120321 | |
| 008 | 201203s 0 0 eng d | ||
| 022 | _a1099-0844 | ||
| 024 | 7 |
_a10.1002/cbf.1801 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAri, Ferda | |
| 245 | 0 | 0 |
_aModulation of protein expression levels and DNA methylation status of breast cancer metastasis genes by anthracycline-based chemotherapy and the demethylating agent decitabine. _h[electronic resource] |
| 260 |
_bCell biochemistry and function _cDec 2011 |
||
| 300 |
_a651-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnthracyclines _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aAzacitidine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDNA Methylation _xdrug effects |
| 650 | 0 | 4 | _aDecitabine |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeoplasm Invasiveness |
| 650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xgenetics |
| 650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xgenetics |
| 700 | 1 | _aNapieralski, Rudolf | |
| 700 | 1 | _aUlukaya, Engin | |
| 700 | 1 | _aDere, Egemen | |
| 700 | 1 | _aColling, Christoph | |
| 700 | 1 | _aHonert, Katja | |
| 700 | 1 | _aKrüger, Achim | |
| 700 | 1 | _aKiechle, Marion | |
| 700 | 1 | _aSchmitt, Manfred | |
| 773 | 0 |
_tCell biochemistry and function _gvol. 29 _gno. 8 _gp. 651-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cbf.1801 _zAvailable from publisher's website |
| 999 |
_c21129411 _d21129411 |
||